Condition: H Pylori Gastritis · H Pylori Infection · H Pylori Eradication · Sponsor: Catalysis SL
Eighty patients will be included and randomized in two groups, one group (40 patients) will be administered 30 ml of the supplement Carminal, once a day, plus therapy for HP gastitis and the control group (40 patients) will be given standard therapy for HP gastritis with placebo. Treatment will begin after complection of upper endoscopy with histology results from biopted gastric mucosa. Treatment with Carminal will be continued after successful HP eradication during 12 weeks. The final evaluation will take place 12 weeks after the last Carminal intake, when control endoscopy with histology will be performed. The study will last approximately 24 weeks.
This description comes directly from the study's public registry record.
Dragana Mijač, MD, PhD · +381 11 3088672 · draganamijac@gmail.com
Always discuss trial participation with your own doctor first.
| Clinical Center of Serbia - Clinic for Gastroenterohepatology | Belgrade, Central Serbia, Serbia | Recruiting |
| Zvezdara Medical Center - Department of Gastroenterology | Belgrade, Central Serbia, Serbia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07179237